Suchergebnisse - "Dexamethasone"

PubPharm (76)

1

Comparison of COVID-19 Preprint and Peer-Reviewed Versions of Studies on Therapies for Critically Ill Patients

enthalten in: Journal of intensive care medicine | 2023

von Morin, C. | Padki, A. | Wong, A. | +4

2

COVID-19 update : An EUA for vilobelimab (Gohibic) for COVID-19

enthalten in: The Medical letter on drugs and therapeutics | 2023

3

Epidural Abscesses as a Complication of Interleukin-6 Inhibitor and Dexamethasone Treatment in a Patient with COVID-19 Pneumonia : A Case Report

enthalten in: Medicina (Kaunas, Lithuania) | 2023

von Ģībietis, V.

4

Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone : A case series

enthalten in: Infection control and hospital epidemiology | 2023

von Côté, F. | Boivin, G. | Loungnarath, V. | +5

5

COVID-19 Pharmacotherapy in Pregnancy : A Literature Review of Current Therapeutic Choices

enthalten in: Viruses | 2023

von Akinosoglou, K. | Schinas, G. | Rigopoulos, E. | +4

6

Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome

enthalten in: PloS one | 2023

von Segú-Vergés, C. | Artigas, L. | Coma, M. | +1

7

Covid-19 update : Tocilizumab (Actemra) FDA-approved for treatment of COVID-19

enthalten in: The Medical letter on drugs and therapeutics | 2023

8

Epidural Abscesses as a Complication of Interleukin-6 Inhibitor and Dexamethasone Treatment in a Patient with COVID-19 Pneumonia: A Case Report

in: Medicina | 2023

von Valdis Ģībietis

9

An EUA for anakinra (Kineret) for COVID-19

enthalten in: The Medical letter on drugs and therapeutics | 2022

10

Utility Of Inflammatory Markers For Tocilizumab In Covid-19 Patients : A Single-Site Retrospective Study

enthalten in: Journal of Ayub Medical College, Abbottabad : JAMC | 2022

von Amir, M. | Ali, U. | Javed, A. | +1

1
2
3
4
5
6
7
8
Nächster »
[8]